The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesion
- 1 January 1994
- journal article
- review article
- Published by Wiley in Annals of Neurology
- Vol. 36 (S1) , S61-S72
- https://doi.org/10.1002/ana.410360716
Abstract
This review surveys the structural terrain of the multiple sclerosis (MS) lesion from the standpoint of its immunologic responsiveness. Similarities in lymphocyte trafficking patterns are noted between MS and its laboratory model, experimental allergic encephalomyelitis (EAE), and in both conditions, the inflammatory response is selective for the central nervous system (CNS). While adhesion molecules abound during the genesis of the MS lesion, none has yet been found that is unusual to this condition and, indeed, many occur in other neurodegenerative states in which inflammation is not a component of the lesion. Cytokines are effective regulators of lymphocyte traffic and adhesion events and most can be located in MS lesions. Of these, tumor necrosis factor-alpha (TNF-alpha) occurs in abundance. Together with its known affinity to effect myelin and oligodendrocyte destruction and to up-regulate adhesion molecule expression, the presence of TNF-alpha renders it an important player in lesion pathogenesis. Demyelination is described as a rapid lytic event, perhaps involving cytokines and immunoglobulin, and structural similarities are common in the patterns seen in MS and EAE. Oligodendrocytes survive the initial stages of lesion formation. Moreover, they are now known to proliferate and elaborate new myelin at the same time as myelin is being degraded. This paradoxical reparatory scenario is apparently a transient event although rims of remyelination persist about the margins of chronic lesions. The speculation is reiterated that the demise of the oligodendrocyte in MS may occur late in lesion formation and may be in part related to the expression of heat shock proteins (specifically, members of the hsp 60 family), potent stimulators of T-cell receptor-gamma delta T cells that have been claimed to have cytolytic activity and that have been located in chronic active MS lesions. In sum, while no single immune system molecule can be assigned as unusual to the CNS in MS, and while there appears to be nothing unique about the manner in which the CNS responds to the inflammation, the true uniqueness of the situation in MS is probably related to the many, normally sequestered, specific antigens within the myelin sheath and the biology of the myelinating cell, the oligodendrocyte.Keywords
This publication has 37 references indexed in Scilit:
- In vivo CNS remyelination: HNK-1 labels newly differentiated oligodendrocytes but not precursorsJournal of Neurocytology, 1993
- Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosisNature, 1993
- Cell death and control of cell survival in the oligodendrocyte lineagePublished by Elsevier ,1992
- Anti—tumor necrosis factor therapy abrogates autoimmune demyelinationAnnals of Neurology, 1991
- Migration of Hematogenous Cells Through the Blood‐Brain Barrier and the Initiation of CNS InflammationBrain Pathology, 1991
- An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.The Journal of Experimental Medicine, 1990
- Shared Human T Cell Receptor V β Usage to Immunodominant Regions of Myelin Basic ProteinScience, 1990
- Tumor necrosis factor identified in multiple sclerosis brain.The Journal of Experimental Medicine, 1989
- On the immunopathology of plaque development and repair in multiple sclerosisJournal of Neuroimmunology, 1988
- Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitroAnnals of Neurology, 1988